Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study.
Level 5 - mechanism / opinion, no new human data
Preclinical animal laboratory study
PubMed 11165387 · doi:10.1016/s0169-328x(00)00269-2
What was done
Non-radioisotopic in situ hybridization was performed on adult rat brain tissue to evaluate the cellular and regional mRNA distribution of the creatine-synthesizing enzymes L-arginine:glycine amidinotransferase (AGAT) and S-adenosyl-L-methionine:N-guanidinoacetate methyltransferase (GAMT), as well as the creatine transporter CRT1.
What was found
The abstract reports qualitative anatomical findings without numerical metrics. AGAT and GAMT mRNA showed ubiquitous expression across both neuronal and glial cell populations throughout the adult rat brain. In contrast, CRT1 mRNA was detected in neurons and oligodendrocytes across the brain but was not expressed in astrocytes, including astrocyte end-feet contacting capillary endothelial cells.
Why it matters
The findings demonstrate that rat brain cells possess the molecular machinery for autonomous de novo creatine synthesis. The absence of CRT1 in astrocytic end-feet reinforces the model that the central nervous system relies primarily on endogenous creatine production rather than transport across the blood-brain barrier.
Limits
The study was conducted entirely in adult rats, which may not fully reflect human neuroanatomy or transporter distribution. The abstract does not report the number of animals examined, quantitative expression levels, or functional protein translation and enzymatic activity.
Cited by
- supports The human body (including the liver and brain) synthesizes between 1 and 3 grams of creatine per day.